Patent · US Active

Ocular allergy treatments with alcaftadine

US8664215B2 · kind B2 · utility

3Cited by

2References

11Claims

0Family size

Assignee

Vistakon Pharmaceuticals, LLC · US

Inventors

Avner Ingerman · Scarsdale, US
Frans Eduard Janssens · Bonheiden, BE
Anton Megens · Beerse, BE
Mark B. Abelson · Andover, US

Key dates

Filing date	Mar 26, 2007
Grant date	Mar 4, 2014
Priority date	—
Expiry date	Oct 12, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, kits, and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof containing alcaftadine or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.